Frisch Financial Group, Inc. Merck & Co., Inc. Transaction History

Frisch Financial Group, Inc.

$333 Million
Q3 2024

A detailed history of Frisch Financial Group, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Frisch Financial Group, Inc. holds 8,924 shares of MRK stock, worth $885,707. This represents 0.31% of its overall portfolio holdings.

Number of Shares

8,924

Previous 8,488 5.14%

Holding current value

$885,707

Previous $1.05 Million 2.95%

% of portfolio

0.31%

Previous 0.32%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $48,461 - $56,230	436 Added 5.14%	8,924 $1.02 Million
Q2 2024 Aug 09, 2024	SELL	$123.8 - $132.96 $9,285 - $9,972	-75 Reduced 0.88%	8,488 $1.05 Million
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $15,853 - $18,473	140 Added 1.66%	8,563 $1.13 Million
Q4 2023 Feb 12, 2024	SELL	$100.18 - $109.02 $5,910 - $6,432	-59 Reduced 0.7%	8,423 $918,000
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $30,164 - $33,498	-293 Reduced 3.34%	8,482 $873,000
Q2 2023 Aug 11, 2023	BUY	$108.61 - $118.38 $30,519 - $33,264	281 Added 3.31%	8,775 $1.01 Million
Q1 2023 May 11, 2023	BUY	$102.94 - $114.86 $24,705 - $27,566	240 Added 2.91%	8,494 $904,000
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $9,268 - $11,883	-106 Reduced 1.27%	8,254 $916,000
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $1,521 - $1,709	-18 Reduced 0.21%	8,360 $720,000
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $4,174 - $4,732	50 Added 0.6%	8,378 $764,000
Q1 2022 May 10, 2022	SELL	$73.51 - $82.4 $63,880 - $71,605	-869 Reduced 9.45%	8,328 $683,000
Q4 2021 Feb 09, 2022	BUY	$72.28 - $90.54 $33,031 - $41,376	457 Added 5.23%	9,197 $704,000
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $2.22 Million - $2.45 Million	-31,040 Reduced 78.03%	8,740 $656,000
Q3 2021 Nov 10, 2021	BUY	$71.68 - $78.83 $2.2 Million - $2.42 Million	30,708 Added 338.49%	39,780 $674,000
Q2 2021 Aug 12, 2021	SELL	$70.31 - $77.77 $8,226 - $9,099	-117 Reduced 1.27%	9,072 $705,000
Q1 2021 May 13, 2021	BUY	$68.86 - $81.11 $4,682 - $5,515	68 Added 0.75%	9,189 $709,000
Q4 2020 Jan 26, 2021	SELL	$71.77 - $79.65 $365,811 - $405,976	-5,097 Reduced 35.85%	9,121 $746,000
Q3 2020 Nov 10, 2020	BUY	$73.18 - $82.95 $327,334 - $371,035	4,473 Added 45.9%	14,218 $1.18 Million
Q2 2020 Aug 06, 2020	BUY	$70.42 - $80.13 $159,712 - $181,734	2,268 Added 30.33%	9,745 $754,000
Q1 2020 May 08, 2020	SELL	$63.36 - $87.82 $238,487 - $330,554	-3,764 Reduced 33.48%	7,477 $575,000
Q4 2019 Jan 28, 2020	BUY	$77.58 - $87.54 $309,311 - $349,021	3,987 Added 54.96%	11,241 $1.02 Million
Q3 2019 Nov 05, 2019	BUY	$76.08 - $82.93 $275,105 - $299,874	3,616 Added 99.4%	7,254 $611,000
Q2 2019 Aug 08, 2019	SELL	$69.84 - $81.59 $262,598 - $306,778	-3,760 Reduced 50.82%	3,638 $305,000
Q1 2019 May 06, 2019	BUY	$69.58 - $79.36 $260,368 - $296,965	3,742 Added 102.35%	7,398 $615,000
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $238,517 - $276,795	3,656 New	3,656 $279,000

Others Institutions Holding MRK

# of Institutions

3,829

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Frisch Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Frisch Financial Group, Inc. with notifications on news.

Account

Frisch Financial Group, Inc. Merck & Co., Inc. Transaction History